VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+46.01%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$648M
AUM Growth
+$648M
(+28%)
Cap. Flow
+$30M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
69.93%
Holding
36
New
9
Increased
7
Reduced
3
Closed
5
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$22.6M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$22.3M |
| 3 |
Terns Pharmaceuticals
TERN
|
$21.8M |
| 4 |
Gossamer Bio
GOSS
|
$20.9M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$20.1M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$41.5M |
| 2 |
Relmada Therapeutics
RLMD
|
$27.8M |
| 3 |
Celldex Therapeutics
CLDX
|
$22.2M |
| 4 |
VistaGen Therapeutics
VTGN
|
$18.2M |
| 5 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$14.5M |
Sector Composition
| 1 | Healthcare | 96.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lyra Therapeutics
LYRA
$11.5M
| $4.63M | 0.71% | 924,170 | – | – |
|
27
Immunocore
IMCR
$1.62B
| $4.44M | 0.69% | +94,605 | New | +$4.44M |
|
|
ATYR
28
aTyr Pharma
ATYR
$527M
| $4.2M | 0.65% | 1,398,889 | – | – |
|
29
Rallybio
RLYB
$22.4M
| $3.89M | 0.6% | 268,532 | – | – |
|
|
AFMD
30
DELISTED
Affimed
AFMD
| $2.94M | 0.45% | 1,428,571 | – | – |
|
|
31
Celldex Therapeutics
CLDX
$1.47B
| $2.11M | 0.33% | 75,000 -790,116 | -91% | -$22.2M |
|
|
32
Travere Therapeutics
TVTX
$1.56B
| – | – | -1,711,102 | Closed | -$41.5M |
|
|
33
VistaGen Therapeutics
VTGN
$102M
| – | – | -20,697,286 | Closed | -$18.2M |
|
34
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -30,000 | Closed | -$913K |
|
|
WHWK
35
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| – | – | -1,173,518 | Closed | -$14.5M |
|
|
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – | -489,618 | Closed | -$8.56M |
|